Boston-based GI Dynamics created a scientific advisory board and named Carel Le Roux, MD, PhD, and Jan Willem Greve, MD, PhD, its first two members. Dr. Le Roux is Ireland-based University College ...

BOSTON--(BUSINESS WIRE)--GI Dynamics® Inc., a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to ...

The road has been long and hard for GI Dynamics getting its EndoBarrier device approval. But new data from a multi-center study of the type II diabetes and obesity treatment device could be a source ...

GI Dynamics’ EndoBarrier had its CE Mark suspended over nonconformances related to its quality management system. Here’s what you should know. 1. SGS United Kingdom Limited issued the suspension. 2.

BOSTON & SYDNEY--(BUSINESS WIRE)--GI Dynamics ®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier ® in Europe, the Middle East and South America has received notification ...

BOSTON, July 11, 2023 /PRNewswire/ -- GI Dynamics, creator of the world's first medical device designed to target the underlying cause of type 2 diabetes, is proud to announce its rebrand to Morphic ...